ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Evome Medical Technologies Inc

Evome Medical Technologies Inc (EVMT)

0.14
0.00
(0.00%)
Closed January 13 4:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.14
Bid
0.135
Ask
0.15
Volume
10,900
0.14 Day's Range 0.14
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.14
Open
0.14
Last Trade
400
@
0.14
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
56,991,000
Dividend Yield
-
PE Ratio
-0.80
Earnings Per Share (EPS)
-0.27
Revenue
62.63M
Net Profit
-15.6M

About Evome Medical Technologies Inc

Sector
Med, Dental, Hosp Eq-whsl
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
East Yorkshire, Gbr
Founded
2015
Evome Medical Technologies Inc is listed in the Med, Dental, Hosp Eq-whsl sector of the TSX Venture Exchange with ticker EVMT. The last closing price for Evome Medical Technologies was $0.14. Over the last year, Evome Medical Technologies shares have traded in a share price range of $ 0.00 to $ 0.00.

Evome Medical Technologies currently has 56,991,000 shares outstanding. The market capitalization of Evome Medical Technologies is $7.98 million. Evome Medical Technologies has a price to earnings ratio (PE ratio) of -0.80.

EVMT Latest News

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 – Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) today reported financial results for the...

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today announced ‎the results from its annual general and special meeting...

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome...

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug...

Evome Medical Technologies Retains irlabs for Investor Relations Services

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered into an agreement ("Agreement") with IR...

Evome Medical Technologies Announces Securities Issuances

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange...

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from...

Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt

NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown...

Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the “Company” or “Evome”) highlighted the strengthening credit relationship with Pathward, N.A. (“Pathward”), the...

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - EVMT

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - EVMT Canada NewsWire VANCOUVER, BC, le 2 avril 2024 VANCOUVER, BC, le 2 avril 2024...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

EVMT - Frequently Asked Questions (FAQ)

What is the current Evome Medical Technologies share price?
The current share price of Evome Medical Technologies is $ 0.14
How many Evome Medical Technologies shares are in issue?
Evome Medical Technologies has 56,991,000 shares in issue
What is the market cap of Evome Medical Technologies?
The market capitalisation of Evome Medical Technologies is CAD 7.98M
What is the 1 year trading range for Evome Medical Technologies share price?
Evome Medical Technologies has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Evome Medical Technologies?
The price to earnings ratio of Evome Medical Technologies is -0.8
What is the cash to sales ratio of Evome Medical Technologies?
The cash to sales ratio of Evome Medical Technologies is 0.2
What is the reporting currency for Evome Medical Technologies?
Evome Medical Technologies reports financial results in CAD
What is the latest annual turnover for Evome Medical Technologies?
The latest annual turnover of Evome Medical Technologies is CAD 62.63M
What is the latest annual profit for Evome Medical Technologies?
The latest annual profit of Evome Medical Technologies is CAD -15.6M
What is the registered address of Evome Medical Technologies?
The registered address for Evome Medical Technologies is SUITE 200E - 1515A BAYVIEW AVENUE, EAST YORKSHIRE, M4G 3B5
What is the Evome Medical Technologies website address?
The website address for Evome Medical Technologies is www.salonaglobal.com
Which industry sector does Evome Medical Technologies operate in?
Evome Medical Technologies operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SQGSpackman Equities Group Inc
$ 3.50
(354.55%)
59.45k
KLMKermode Resources Ltd
$ 0.01
(100.00%)
1.42M
GNFIGenifi Inc
$ 0.01
(100.00%)
2k
XBOTRealbotix Corp
$ 0.61
(84.85%)
6.9M
JADEJade Leader Corp
$ 0.04
(60.00%)
177k
AJAAJA Health and Wellness Inc
$ 0.035
(-53.33%)
2k
BYM.HBaymount Incorporated
$ 0.005
(-50.00%)
1,000
ETUE2gold Inc
$ 0.005
(-50.00%)
12.29k
ENTGEntourage Health Corp
$ 0.005
(-50.00%)
16.04k
WWA.PWhitewater Acquisition Corp
$ 0.14
(-48.15%)
5k
XBOTRealbotix Corp
$ 0.61
(84.85%)
6.9M
QNCQuantum Emotion Corp
$ 0.90
(-19.64%)
4.37M
GPUSAlset AI Ventures Inc
$ 0.185
(-11.90%)
4.1M
RHCRoyal Helium Ltd
$ 0.02
(0.00%)
3.47M
THRMTherma Bright Inc
$ 0.04
(-20.00%)
2.71M

Discussion

View Full Feed
Hi_Lo Hi_Lo 1 minute ago
Lol!! I want profits!! What you want helps me in no way!!
Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents pumping liars like you from making profits. And that's part of my goal - and to help people know the facts about this scam
BCAP
DiamondHealer95 DiamondHealer95 5 minutes ago
What do you expect and how can you back your thoughts? Thanks
KBLB
DiamondHealer95 DiamondHealer95 11 minutes ago
I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

Also, in my Arby's voice "I have the
KBLB
DiamondHealer95 DiamondHealer95 15 minutes ago
We've invested similarly
KBLB
sunspotter sunspotter 26 minutes ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 37 minutes ago
Marc loved your ides
tinojax tinojax 38 minutes ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 40 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 56 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 56 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 57 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 58 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 1 hour ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 1 hour ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 1 hour ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 1 hour ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 1 hour ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 1 hour ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 1 hour ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 1 hour ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 1 hour ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 1 hour ago
He would smother any question with words.

Your Recent History

Delayed Upgrade Clock